Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tocagen Inc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Tocagen Inc since year 2005.
Table 2 shows the detailed insider transactions of Tocagen Inc since 2005.
The reporting company's ticker symbol is TOCA. The reporting company's CIK number is 1419041.
The total value of stock buying since 2005 is $1,425,000.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2017-04-19||Das Asha (SVP & Chief Medical Officer)||Buy||2,500||10.00||25,000|
|2017-04-19||Hasnain Faheem (Director)||Buy||100,000||10.00||1,000,000|
|2017-04-19||Schimmel Paul (Director)||Buy||10,000||10.00||100,000|
|2017-04-19||Foletta Mark G (EVP & Chief Financial Officer)||Buy||5,000||10.00||50,000|
|2017-04-19||Gruber Harry E (President, Research & Devel)||Buy||25,000||10.00||250,000|
Insider trading activities including stock purchases, stock sales, and option exercises of TOCA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tocagen Inc (symbol TOCA, CIK number 1419041) see the Securities and Exchange Commission (SEC) website.